MWM
AGN

Maltin Wealth Management’s Allergan plc AGN Stock Holding History

Maltin Wealth Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-5,221
Closed -$925K – 93
2020
Q1 		$925K Buy
5,221
+2,300
+79% +$433K 0.79% 34
2019
Q4 		$558K Buy
+2,921
New +$527K 0.36% 44

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Maltin Wealth Management's AGN Position: Q2 2020 in Review

Maltin Wealth Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 5,221 shares — an estimated $925K sold.

Maltin Wealth Management first reported a position in AGN in Q4 2019 and held it in 2 quarters. The position peaked at $925K in Q1 2020. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Maltin Wealth Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Maltin Wealth Management sold 5,221 Allergan plc shares in Q2 2020, an estimated $925K.
  • Maltin Wealth Management first reported a position in Allergan plc in Q4 2019 and held it in 2 quarters.
  • Maltin Wealth Management's Allergan plc position peaked at $925K in Q1 2020.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Maltin Wealth Management's 13F filing for Q2 2020, filed 5 Aug 2020.